Life at the Johns Hopkins School of Medicine
Guest blogger, Madeline Kane, is a genetic epidemiology Master of Science candidate at the Johns Hopkins University Bloomberg School of Public Health. If you’ve ever… Read More »Teaching Cancer Cells to Self-Sabotage
Working with biological samples has its ups and downs. Every Ph.D. student, postdoc and scientific researcher working with cells, tissues, animals or other living organisms… Read More »Organoids — frustrating and full of promise
Next generation cancer diagnostics are poised to change the way that cancer is detected and treated. Ph.D. candidate Roshan Chikarmane shares his perspectives on the teams and technologies that are leading the charge.
In a 1909 manuscript titled “Ueber den jetzigen Stand der Chemotherapie” (“About the Current State of Chemotherapy”), Nobel laureate Paul Ehrlich proclaimed, “We must learn… Read More »Engineering Magic Bullets for Pancreatic Cancer
Melanoma cells stained with PTRF (in red), RPA194 (in green) and nucleus stained in blue. RPA194 is the main subunit of the RNA polymerase I… Read More »The Colorful World of Cancer Drug Discovery
While the word cancer treatment may identify everything from chemotherapy to radiation, there is significant variance between the type of cancer and its responsiveness to… Read More »Using Epigenetics to Fight Tumors
My fifth grade world — a typical one concerned with classes, friends, recess, lunch menus and dreading middle school — forever changed one day, when… Read More »When Cancer Hits Home: A Researcher’s Call to Action
When scientists and clinicians hear the words “clinical trial”, we may think of hope, discovery, and a new chance at life. But for racial and… Read More »Understanding Disparities in Clinical Trial Enrollment
Yoshinori Ohsumi of the University of Tokyo was recently awarded the 2016 Nobel Prize in Physiology or Medicine for his work in mechanisms for autophagy.… Read More »Nobel Prize Winning Research May Lead to New Therapies for Cancer, Alzheimer’s
During the final month of 2015, Congress passed a $1.1 trillion federal spending bill that would keep the government fiscally solvent into September 2016. Along with… Read More »Recent NIH Funding and Moonshot Initiatives: Are they They Helping or Hindering?